0001209191-13-058319.txt : 20131220 0001209191-13-058319.hdr.sgml : 20131220 20131220200209 ACCESSION NUMBER: 0001209191-13-058319 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131218 FILED AS OF DATE: 20131220 DATE AS OF CHANGE: 20131220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC CENTRAL INDEX KEY: 0001001233 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 680359556 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 5109706000 MAIL ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANPHIER EDWARD O II CENTRAL INDEX KEY: 0001234386 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30171 FILM NUMBER: 131292949 MAIL ADDRESS: STREET 1: C/O SANGAMO BIOSCIENCES IN STE.A-100 STREET 2: POINT RICHMOND TECH CENTER 501 CANA BLVD CITY: RICHMOND STATE: CA ZIP: 94804 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-12-18 0 0001001233 SANGAMO BIOSCIENCES INC SGMO 0001234386 LANPHIER EDWARD O II C/O SANGAMO BIOSCIENCES INC. POINT RICHMOND TECH CNTR, 501 CANAL BLVD RICHMOND CA 94804 1 1 0 0 President & CEO Common Stock 2013-12-18 4 M 0 50000 6.39 A 345000 D Common Stock 2013-12-18 4 S 0 50000 12.4741 D 295000 D Common Stock 1595054 I By Trust Common Stock 100000 I By Trust for Daughter Employee Stock Option (Right to Buy) 6.39 2013-12-18 4 M 0 50000 0.00 D 2014-04-21 Common Stock 50000 5281 D Includes 100,000 shares, 120,000 shares, and 75,000 shares subject to restricted stock units granted on December 8, 2011, December 6, 2012, and December 12, 2013, respectively, that will be issued as such units vest in accordance with their terms. On December 18, 2013, the Reporting Person transferred 52,602 shares directly held by him to the Edward O. Lanphier II and Cameron M. Lanphier Trust U/T/A August 30, 2002, Edward O. Lanphier II and Cameron M. Lanphier, Trustees (?Lanphier Trust?). The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2013. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.41 to $12.48, inclusive. The Reporting Person undertakes to provide to Sangamo BioSciences, Inc., any security holder of Sangamo BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. These shares are held in the Lanphier Trust. The Reporting Person disclaims beneficial ownership of the shares held by his child and this report shall not be deemed to be an admission that Mr. Lanphier is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. All shares underlying this option are vested and immediately exercisable, and such option will expire on April 21, 2014. /s/ Florence Tam, attorney-in-fact 2013-12-20